CREATIVE FINANCIAL DESIGNS INC /ADV - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREATIVE FINANCIAL DESIGNS INC /ADV ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$38,645
+0.9%
3790.0%0.01%0.0%
Q2 2023$38,284
+12.0%
379
+2.2%
0.01%
+25.0%
Q1 2023$34,168
-14.6%
371
-15.9%
0.00%
-33.3%
Q4 2022$40,008
+17.7%
4410.0%0.01%0.0%
Q3 2022$34,000
+30.8%
441
+42.7%
0.01%
+50.0%
Q2 2022$26,000
+36.8%
309
+41.1%
0.00%
+33.3%
Q1 2022$19,000
+90.0%
219
+82.5%
0.00%
+50.0%
Q4 2021$10,000
-54.5%
120
-55.7%
0.00%
-50.0%
Q3 2021$22,000
-12.0%
2710.0%0.00%0.0%
Q2 2021$25,000
+8.7%
2710.0%0.00%0.0%
Q1 2021$23,000
-11.5%
2710.0%0.00%
-33.3%
Q4 2020$26,000
-7.1%
271
-15.3%
0.01%
-14.3%
Q3 2020$28,000
-3.4%
320
-3.9%
0.01%
-22.2%
Q2 2020$29,000
+262.5%
333
+262.0%
0.01%
+125.0%
Q1 2020$8,000
-20.0%
92
-11.5%
0.00%0.0%
Q4 2019$10,000
+11.1%
1040.0%0.00%
-20.0%
Q3 2019$9,0000.0%1040.0%0.01%0.0%
Q2 2019$9,000
-18.2%
104
-8.8%
0.01%
-28.6%
Q1 2019$11,000
+1000.0%
114
+850.0%
0.01%
+600.0%
Q4 2018$1,000
-66.7%
12
-70.0%
0.00%
-50.0%
Q3 2018$3,000
-70.0%
40
-69.7%
0.00%
-66.7%
Q2 2018$10,000
-9.1%
1320.0%0.01%
-14.3%
Q1 2018$11,000
+10.0%
132
+10.0%
0.01%0.0%
Q4 2017$10,0000.0%1200.0%0.01%
+16.7%
Q3 2017$10,0000.0%1200.0%0.01%0.0%
Q2 2017$10,000
+25.0%
1200.0%0.01%0.0%
Q1 2017$8,000
-20.0%
120
-16.7%
0.01%
-25.0%
Q4 2016$10,0001440.01%
Other shareholders
NOVARTIS A G shareholders Q3 2021
NameSharesValueWeighting ↓
Martin Investment Management, LLC 315,999$27,640,0006.85%
GODSEY & GIBB, INC 191,150$16,720,0005.36%
MANAGED ASSET PORTFOLIOS, LLC 386,923$33,844,0004.78%
PROFESSIONAL ADVISORY SERVICES INC 278,786$24,385,0003.32%
SCHARF INVESTMENTS, LLC 1,262,077$110,405,0003.27%
Camber Capital Management LP 1,000,000$87,470,0003.01%
GARLAND CAPITAL MANAGEMENT INC 47,455$4,151,0002.86%
First Fiduciary Investment Counsel, Inc. 170,223$14,889,0002.64%
WILKINS INVESTMENT COUNSEL INC 132,790$11,615,0002.56%
Lowell Blake & Associates Inc. 69,772$6,103,0002.40%
View complete list of NOVARTIS A G shareholders